Waystar Holding
- Market cap
- 4.94B
- P/E (TTM)i
- 36.81
- P/Bi
- 1.24
- EPSi
- 0.61
- Div yieldi
- 0.00%
- 52W posi
- 37%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Health Information Services
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Waystar Holding (WAY) | 4.94B | 36.81 | 1.24 | 0.00% |
| Veeva Systems (VEEV) | 45.74B | 46.31 | 6.15 | 0.00% |
| Tempus AI (TEM) | 12.69B | -48.85 | 28.53 | 0.00% |
| BrightSpring Health Services (BTSG) | 12.62B | 38.67 | 6.16 | 0.00% |
| Hinge Health (HNGE) | 7.90B | 73.14 | 22.93 | 0.00% |
| HealthEquity (HQY) | 7.60B | 33.18 | 3.82 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 26.5% below Morningstar's fair value estimate.
Fair value
While Waystar Holding Corp may seem inexpensive after its substantial price decline over the past year, we've limited its rating to 3 stars to account for the possibility that it may represent a value trap. The stock currently trades at a 19% discount to our quantitative fair value estimate of $32.59 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's valuation metrics bolster our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 83.7% falls in the top 40% globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 6.3%, a core component of profitability, ranks in the top 40% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.